Shoulder Innovations Inc. Files for $105 Million IPO to Advance AI-Enhanced Shoulder Replacement Systems

Shoulder Innovations, Inc. Files for IPO to Raise up to $105 Million Amid U.S. IPO Market Recovery

According to the latest disclosed documents, the company plans to issue 5 million shares, with a price range of $19 to $21 per share. If calculated at the upper limit of the price range, the valuation of Shoulder Innovations will reach $418 million. Roadshow materials obtained by Bloomberg show that the company is expected to be priced on July 30.

Shoulder Innovations, founded in 2009, focuses on developing advanced implant systems for shoulder replacement surgeries. The prospectus shows that the company integrates artificial intelligence (AI) and machine learning technologies into preoperative surgical planning to enhance surgical accuracy and efficiency.

Financial data shows that in the three months ended March 31, 2024, the company achieved revenue of $10.1 million, a significant increase from $7.2 million in the same period last year. However, losses also widened, with net loss expanding from $3.6 million last year to $4.7 million.

In terms of equity structure, US Venture Partners, a U.S.-based venture capital firm, is the company's largest shareholder and is expected to hold 13.5% of the shares after the IPO. Funds affiliated with Fidelity Investments will hold 12.5% of the shares after convertible bonds are converted into common stock. Glide Healthcare, a Netherlands-based healthcare investment firm, will hold 11.4%, and Lightstone Ventures will hold 8.1%.

This IPO is jointly underwritten by Morgan Stanley, Goldman Sachs Group, and Piper Sandler. Shoulder Innovations plans to list on the New York Stock Exchange under the ticker symbol "SI."